FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Sought on Petition for OTC Denture Repair Kits

[ Price : $8.95]

Federal Register notice: FDA seeks comments on a petition from an undisclosed applicant requesting exemption from premarket notifi...

Guide on Same Procedure Exception for Tissue Products

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance on Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions an...

Guide on HCT/P Minimal Manipulation and Homologous Use

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Regulatory Considerations for Human Cells, Tissues, and Cellular ...

White House Puts 2015 Opioid Crisis Cost at $500 Billion

[ Price : $8.95]

A new White House report estimates that the ongoing opioid crisis cost the U.S. $504 billion in 2015 and led to over 33,000 Americ...

Janssen Biosimilar Patent Infringement Complaint Filed

[ Price : $8.95]

Federal Register notice: FDA acknowledges that an applicant for a proposed biosimilar product notified the agency that a patent in...

Guide on UDI Direct Device Markings

[ Price : $8.95]

Federal Register notice: FDA makes available a guidance entitled Unique Device Identification: Direct Marking of Devices.

FDA Approves Kalos AUVI-Q for Infants

[ Price : $8.95]

FDA approves a Kalo supplemental NDA for AUVI-Q (epinephrine injection, USP) 0.1 mg, for treating life-threatening allergic reacti...

Breakthrough, Orphan Drug Status for PellePharm Drug

[ Price : $8.95]

FDA grants PellePharm a breakthrough therapy designation and orphan drug designation for topical patidegib for patients with Gorli...

Latest Federal Register Notices

[ Price : $8.95]

FDA Review posts the Federal Register notices for the week ending 11/17/2017.

Guide on Cell/Tissue-Based Product Regulatory Considerations

[ Price : $8.95]

FDA releases a guidance on Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Mi...